Capital Management Associates Inc’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.22M Buy
12,672
+1,555
+14% +$362K 0.65% 25
2026
Q1
$2.72M Sell
11,117
-189
-2% -$44K 0.61% 25
2025
Q4
$2.34M Buy
11,306
+1,908
+20% +$377K 0.52% 29
2025
Q3
$1.74M Sell
9,398
-280
-3% -$48K 0.47% 32
2025
Q2
$1.48M Buy
9,678
+1,310
+16% +$201K 0.47% 34
2025
Q1
$1.39M Sell
8,368
-689
-8% -$108K 0.31% 45
2024
Q4
$1.31M Buy
9,057
+221
+3% +$34.2K 0.49% 33
2024
Q3
$1.43M Buy
8,836
+4,842
+121% +$771K 0.59% 29
2024
Q2
$584K Buy
3,994
+193
+5% +$28.7K 0.35% 41
2024
Q1
$601K Sell
3,801
-366
-9% -$58.3K 0.44% 35
2023
Q4
$653K Buy
+4,167
New +$639K 0.38% 36

Other funds holding JNJ

Capital Management Associates Inc's JNJ Position: Q2 2026 in Review

Capital Management Associates Inc increased its Johnson & Johnson (JNJ) stake by 14% in Q2 2026, buying an estimated $362K and bringing the position to 12,672 shares worth $3.22M. The position accounts for 0.65% of the portfolio, ranked #25.

Capital Management Associates Inc first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. 2,503 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Capital Management Associates Inc held 12,672 shares of Johnson & Johnson worth $3.22M as of Q2 2026.
  • Capital Management Associates Inc bought 1,555 Johnson & Johnson shares in Q2 2026, an estimated $362K.
  • Johnson & Johnson made up 0.65% of Capital Management Associates Inc's portfolio in Q2 2026, its #25 holding.
  • Capital Management Associates Inc first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • 2,503 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Capital Management Associates Inc's 13F filing for Q2 2026, filed 22 Jul 2026.